103754-45-6 Usage
Uses
Due to the limited information available on the uses, properties, or hazards of 2-(2,4-DICHLORO-PHENYL)-SUCCINIC ACID, it is not possible to provide a comprehensive list of its applications. However, based on its chemical structure, it can be inferred that it may have potential applications in various industries, such as:
Used in Chemical Synthesis:
2-(2,4-DICHLORO-PHENYL)-SUCCINIC ACID may be used as an intermediate or building block in the synthesis of more complex organic compounds, particularly those involving benzene rings and halogenated groups.
Used in Research and Development:
In the field of organic chemistry, 2-(2,4-DICHLORO-PHENYL)-SUCCINIC ACID could be used as a research compound to study its reactivity, properties, and potential applications in various chemical reactions.
Check Digit Verification of cas no
The CAS Registry Mumber 103754-45-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,3,7,5 and 4 respectively; the second part has 2 digits, 4 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 103754-45:
(8*1)+(7*0)+(6*3)+(5*7)+(4*5)+(3*4)+(2*4)+(1*5)=106
106 % 10 = 6
So 103754-45-6 is a valid CAS Registry Number.
InChI:InChI=1/C10H8Cl2O4/c11-5-1-2-6(8(12)3-5)7(10(15)16)4-9(13)14/h1-3,7H,4H2,(H,13,14)(H,15,16)
103754-45-6Relevant academic research and scientific papers
Makosza,Marcinowicz
, p. 1311 - 1312 (2001)
Alkylation of arylacetonitriles with potassium chloroacetate proceeds selectively leading to 3-cyano-3-arylpropionic acids, which are directly hydrolyzed to arylsuccinic acids.
ALLOSTERIC PROTEIN KINASE MODULATORS
-
Page/Page column 72, (2010/04/30)
The invention provides specific small molecule compounds that allosterically regulate the activity or modulate protein-protein interactions of AGC protein kinases and the Aurora family of protein kinases, methods for their production, pharmaceutical compositions comprising same, and their use for preparing medicaments for the treatment and prevention of diseases related to abnormal activities of AGC protein kinases or of protein kinases of the Aurora family.
